Vimarsana
Biggest News Aggregation in the World

Page 45 - Lucy Lu News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Lucy Lu. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Lucy Lu Today - Breaking & Trending Today

Scientists skeptical over Chinese firm's Covid-19 drug claims, firm's stocks surge - Vimarsana News

Scientists skeptical over Chinese firm's Covid-19 drug claims, firm's stocks surge

Scientists skeptical over Chinese firm's Covid-19 drug claims, firm's stocks surge Reuters Chinese Covid drug Chinese biotech firm Kintor Pharmaceutical Limited saw its stock price jump by more than 20% the day after it announced on April 25 that it had "completed the first patient enrollment and dosing" in a late-stage U.S. clinical trial of its experimental COVID-19 treatment. It was the company's latest announcement about the progress of the drug, Proxalutamide. The Hong Kong-listed company's stock price has nearly quadrupled since March 1 as some analysts wrote about the ...

Source: msn.com
Chinese firm's COVID-19 drug claims draw skepticism - Vimarsana News

Chinese firm's COVID-19 drug claims draw skepticism

Chinese biotech firm Kintor Pharmaceutical Limited saw its stock price jump by more than 20% the day after it announced on April 25 that it had "completed the first patient enrollment and dosing" in a late-stage U.S. clinical trial of its experimental COVID-19 treatment.

Chinese firm's COVID-19 drug claims draw scientists' ... - Vimarsana News

Chinese firm's COVID-19 drug claims draw scientists' ...

By Gabriel Stargardter May 14 (Reuters) - Chinese biotech firm Kintor Pharmaceutical Limited saw its stock price jump by more than 20% the day after it announced on April 25 that it had "completed the first patient enrollment and dosing" in a late-stage U.S. clinical trial of its experimental COVID-19 treatment. It was the company's latest announcement about the progress of the drug, Proxalutamide. The Hong Kong-listed company's stock price has nearly quadrupled since March 1 as some analysts wrote about the big sales potential for a COVID-19 treatment. Kintor has seen its market capitalizati...

Source: trust.org
Covid-19 pandemic: Food worries in Cambodia's red zones, new Chinese drug under scrutiny - Vimarsana News

Covid-19 pandemic: Food worries in Cambodia's red zones, new Chinese drug under scrutiny

Text Size: A+ New Delhi: The Covid-19 pandemic continues to wreak havoc across the world — the latest count being more than 16,18,35,227 cases and 33,58,658 deaths. The Centers for Disease Control and Prevention (CDC) in the US announced the lifting of mask-wearing for vaccinated people Thursday leaves epidemiologists surprised and, Cambodia’s Covid red zones go hungry and more. ThePrint brings you some stories from around the world on the pandemic to keep you updated. US guidance on masks leaves epidemiologists surprised  When the US’ Centers for Disease Control and Preventio...

Chinese firm's COVID-19 drug claims draw scientists' scepticism - Vimarsana News

Chinese firm's COVID-19 drug claims draw scientists' scepticism

  >>  Reuters Published: 14 May 2021 08:50 AM BdST Updated: 14 May 2021 08:50 AM BdST People walk along at a street, following the outbreak of the coronavirus disease, in Shanghai, China May 10, 2021. REUTERS Chinese biotech firm Kintor Pharmaceutical Limited saw its stock price jump by more than 20% the day after it announced on April 25 that it had "completed the first patient enrolment and dosing" in a late-stage US clinical trial of its experimental COVID-19 treatm...